Inorganic selenium retards progression of experimental hormone refractory prostate cancer

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 907-910

  Corcoran, Niall M ^a   Najdovska, Meri ^a,b   Costello, Anthony J ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiogenesis inhibitors; Diet; Prostate; Prostatic neoplasms; Selenium

Indexed keywords

DRINKING WATER; ENZYME; METHYLSELENOCYSTEINE; SELENATE; SELENIUM; SELENOMETHIONINE; TRACE ELEMENT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; LIFE EXPECTANCY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; NUTRIENT; PALLIATIVE THERAPY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; YEAST;

EID: 0345868261     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000092859.16817.8e     Document Type: Article

References (19)

1. Abbas, F. and Scardino, P. T.: The natural history of clinical prostate carcinoma. Cancer, 80: 827, 1997
2. Combs, G. F., Jr., Clark, L. C. and Turnbull, B. W.: An analysis of cancer prevention by selenium. Biofactors, 14: 153, 2001
3. Burk, R. F.: Selenium, an antioxidant nutrient. Nutr Clin Care, 5: 75, 2002
4. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J. et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276: 1957, 1996
5. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B. et al: Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90: 1219, 1998
6. Nomura, A. M., Lee, J., Stemmermann, G. N. and Combs, G. F., Jr.: Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 9: 883, 2000
7. Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D. et al: A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev, 24: 305, 2000
8. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R. et al: SELECT: the next prostate cancer prevention trial. J Urol, 166: 1311, 2001
9. Menter, D. G., Saibichi, A. L. and Lippman, S. M.: Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev, 9: 1171, 2000
10. Kotrebai, M., Birringer, M., Tyson, J. F., Block, E. and Uden, P. C.: Selenium speciation in enriched and natural samples by HPLC-ICP-MS and HPLC-ESI-MS with perfluorinated carboxylic acid ion-pairing agents. Analyst, 125: 71, 2000
11. Ip, C.: Lessons from basic research in selenium and cancer prevention. J Nutr, 128: 1845, 1998
12. Combs, J. F., Jr.: Selenium. In: Nutrition and Cancer Prevention. Edited by T. Moon and M. Micozzi. New York: Marcel Dekker, pp. 389-429, 1989
13. Combs, G. F., Jr. and Gray, W. P.: Chemopreventive agents: selenium. Pharmacol Ther, 79: 179, 1998
14. Combs, G. F., Jr., Hodgson, A. M. and Clark, L. C.: Effects of selenium supplementation on the antioxidant status of free-living Americans. FASEB J, 11: 264, 1997
15. Folkman, J.: Tumor angiogenesis: therapeutic implications. N Engl J Med, 285: 1182, 1971
16. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. and Folkman, J.: Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol, 143: 401, 1993
17. Jiang, C., Ganther, H. and Lu, J.: Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol Carcinog, 29: 236, 2000
18. Jacobs, M. M., Shubik, P. and Feldman, R.: Influence of selenium on vascularization in the hamster cheek pouch. Cancer Lett, 9: 353, 1980
19. Jiang, C., Jjang, W., Ip, C., Ganther, H. and Lu, J.: Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog, 26: 213, 1999